End Prescription Drug Ads Now Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
This bill prohibits drug manufacturers from using direct-to-consumer advertising, such as television, radio, print, digital platforms, and social media, to promote their prescription drugs. It aims to limit the influence of these advertisements on consumer choices and healthcare decisions. The bill specifically targets drugs approved under the Federal Food, Drug, and Cosmetic Act and licensed under the Public Health Service Act, ensuring a consistent application of the ban. The law will take effect 30 days after the bill’s passage.
Key provisions
- Bans direct-to-consumer advertising of prescription drugs.
- Defines ‘direct-to-consumer advertising’ to include various promotional channels.
- Applies to drugs approved under the Federal Food, Drug, and Cosmetic Act.
- Applies to drugs licensed under the Public Health Service Act.
- Establishes a 30-day period for enforcement after enactment.
- Targets advertising conducted within the 30-day period preceding the ban's implementation.
- Addresses advertising through television, radio, print media, digital platforms, and social media.
- Amends Section 502 of the Federal Food, Drug, and Cosmetic Act.
Who is affected
- Drug Manufacturers
- Consumers
- Healthcare Providers
- Pharmaceutical Industry
- Advertising Agencies
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
7 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours